Apax news

You are viewing "All sector" news. Your search returned 169 articles.

Items: 6
Page index: 1
Total pages: 29
Total items: 169
Page size: 6

11 January 2017

Apax Funds to sell an approximate 48 percent stake in GlobalLogic Inc. to Canada Pension Plan Investment Board

Canada Pension Plan Investment Board and Apax Partners LLP announced today that CPPIB has signed a definitive agreement to acquire an approximate 48 percent stake in GlobalLogic Inc., a global leader in digital product development services, from funds advised by Apax. Apax funds will retain an equal stake to CPPIB in the company.

Apax Funds to sell an approximate 48 percent stake in GlobalLogic Inc. to Canada Pension Plan Investment Board  

20 December 2016

Apax Partners closes $9 billion global private equity fund

London and New York Apax Partners LLP (“Apax”), a leading global private equity advisory firm, today announced the successful final close of the Apax IX fund (“Apax IX”) at its hard cap of $9 billion.

 

12 December 2016

Funds advised by Apax Partners LLP acquire remaining stake in Unilabs from Nordic Capital and Apax Partners France

The joint owners of Switzerland-based Unilabs, private equity funds Apax Europe VI, Nordic Capital Fund VI and Apax France VII, announced today that Nordic Capital and Apax Partners France have accepted an offer from Apax IX, advised by Apax Partners LLP, for the acquisition of their respective stakes in Unilabs.

Funds advised by Apax Partners LLP acquire remaining stake in Unilabs from Nordic Capital and Apax Partners France  

4 October 2016

BD and Apax Partners announce closing of joint venture to launch global respiratory business

Becton, Dickinson and Company, a leading global medical technology company, and Apax Partners, today announced the launch of a joint venture – Vyaire Medical – a standalone, global respiratory solutions company. 

BD and Apax Partners announce closing of joint venture to launch global respiratory business  

4 October 2016

Invent Farma and neuraxpharm appoint new group CEO

Following the acquisitions of Invent Farma and neuraxpharm by funds advised by Apax Partners, Stephan Walz has been appointed Chief Executive Officer. He will assume the newly-created role of Group CEO and will be leading Invent Farma’ and neuraxpharm’s activities across all markets.

Invent Farma and neuraxpharm appoint new group CEO  

27 September 2016

Apax Funds agree to sell Plantasjen to Ratos

Funds advised by Apax Partners agree to sell Plantasjen to Ratos.

Apax Funds agree to sell Plantasjen to Ratos  

 

Search our news

Global press contact

Greenbrook Communications
t: +44 20 7952 2000
apax@greenbrookpr.com

Kate Albert
t: +44 20 7872 6300
kate.albert@apax.com

See all Press contacts

Email alerts

To keep up with our latest news Sign-up here